The influence of low calcium dialysate on left ventricular diastolic function in peritoneal dialysis patients

References

• Barberato SH, Bucharles SG, Sousa AM, et al. Prevalence and prognostic impact of diastolic dysfunction in patients with chronic kidney disease on hemodialysis. Arq Bras Cardiol. 2010; 94:457–462.
   PubMed Web of Science ®Google Scholar
• Liang J, Wang Z, Liu G, Zhan J, Jiang L, Jiang Z. Association of dialysate calcium concentration with fetuin a level and carotid intima-media thickness in peritoneal dialysis patients. Ren Fail. 2014; 36:65–68.
   PubMed Web of Science ®Google Scholar
• Nappi SE, Saha HHT, Virtanen VK, Mustonen JK, Pasternack AI. Hemodialysis with high-calcium dialysate impairs cardiac relaxation. Kidney Int. 1999;55:1091–1096.
   PubMed Web of Science ®Google Scholar
• Tuncer M, Ermis C, Suleymanlar G, Yakupoglu G, Ersoy FF. Low calcium dialysate increases cardiac relaxation in CAPD patients. Perit Dial Int. 2002;22:714–718.
   PubMed Web of Science ®Google Scholar
• Kim JK, Kim SG, Kim MG, et al. Left ventricular diastolic dysfunction as a predictor of rapid decline of residual renal function in patients with peritoneal dialysis. J Am Soc Echocardiogr. 2012;25:411–420.
   PubMed Web of Science ®Google Scholar
• Atas N, Erten Y, Okyay GU, et al. Left ventricular hypertrophy and blood pressure control in automated and continuous ambulatory peritoneal dialysis patients. Ther Apher Dial. 2014;18:297–304.
   PubMed Web of Science ®Google Scholar
• Erixon M, Wieslander A, Lindén T, et al. How to avoid glucose degradation products in peritoneal dialysis fluids. Perit Dial Int. 2006; 26:490–497.
   PubMed Web of Science ®Google Scholar
• Matsui K, Kamijo-Ikemori A, Imai N, et al. Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD. Clin Exp Nephrol. 2016;20:195–203.
   PubMed Web of Science ®Google Scholar
• Formentini I, Bobadilla M, Haefliger C, et al. Current drug development challenges in chronic kidney disease (CKD) – Identification of individualized determinants of renal progression and premature cardiovascular disease (CVD). Nephrol Dial Transplant. 2012;27:iii81–iii88.
   PubMed Web of Science ®Google Scholar
• Silberberg DS, Barre P, Prichard S, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989;36:286–290.
   PubMed Web of Science ®Google Scholar
• Kim JK, Moon SJ, Park HC, et al. Effects of lowering dialysate calcium concentrations on arterial stiffness in patients undergoing hemodialysis. Korean J Intern Med. 2011;26:320–327.
   PubMedGoogle Scholar
• Wang AY, Brimble KS, Brunier G, et al. ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I – Assessment and management of various cardiovascular risk factors. Perit Dial Int. 2015;35:379–387.
   PubMed Web of Science ®Google Scholar
• Georgianos PI, Agarwal R. Aortic stiffness, ambulatory blood pressure, and predictors of response to antihypertensive therapy in hemodialysis. Am J Kidney Dis. 2015;66:305–312.
   PubMed Web of Science ®Google Scholar
• LeBoeuf A, Mac-Way F, Utescu MS, et al. Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis. Nephrol Dial Transplant. 2011;26:3695–3701.
   PubMed Web of Science ®Google Scholar
• Wilund KR, Tomayko EJ, Wu PT, et al. Intradialytic exercise training reduces oxidative stress and epicardial fat: A pilot study. Nephrol Dial Transplant. 2010;25:2695–2701.
   PubMed Web of Science ®Google Scholar
• Baykan M, Erem C, Erdogan T, et al. Assessment of left ventricular diastolic function and the Tei index by tissue Doppler imaging in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf). 2007;66:483–488.
   PubMed Web of Science ®Google Scholar
• Lavine SJ. Effect of heart rate and preload on index of myocardial performance in the normal and abnormal left ventricle. J Am Soc Echocardiogr. 2005;18:133–141.
   PubMed Web of Science ®Google Scholar
• Lacorte JC, Cabreriza SE, Rabkin DG, et al. Correlation of the Tei index with invasive measurements of ventricular function in a porcine model. J Am Soc Echocardiogr. 2003;16:442–447.
   PubMed Web of Science ®Google Scholar
• Blanchard DG, Malouf PJ, Gurudevan SV, et al. Utility of right ventricular Tei index in the noninvasive evaluate on of chronic thromboembolic pulmonary hypertension before and after Pulmonary thromboendarterectomy. JACC Cardiovasc Imaging. 2009;2:143–149.
   PubMed Web of Science ®Google Scholar
• Adeniran I, MacIver DH, Hancox JC, et al. Abnormal calcium homeostasis in heart failure with preserved ejection fraction is related to both reduced contractile function and incomplete relaxation: An electromechanically detailed biophysical modeling study. Front Physiol. 2015; 20:78.
   Google Scholar
• Zhang L, Nan C, Chen Y, et al. Calcium desensitizer catechin reverses diastolic dysfunction in mice with restrictive cardiomyopathy. Arch Biochem Biophys. 2015;573:69–76.
   PubMed Web of Science ®Google Scholar
• Ma T, Ding G. Effects of residual renal function on left ventricle and analysis of related factors in patients with hemodialysis. Ren Fail. 2013;35:198–203.
   PubMed Web of Science ®Google Scholar
• Wen Y, Guo Q, Yang X, et al. High glucosee concentrations in peritoneal dialysate are associated with all-cause and cardiovascular disease mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 2015;35:70–77.
   PubMed Web of Science ®Google Scholar
• Liao CT, Chen YM, Shiao CC, et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant. 2009;24:2909–2914.
   PubMed Web of Science ®Google Scholar
• Koo HM, Doh FM, Kim CH, et al. Changes in echocardiographic parameters according to the rate of residual renal function decline in incident peritoneal dialysis patients. Medicine (Baltimore). 2015;94:e427.
   Google Scholar
• Hagg-Weber M, Kramer R, Haake R, et al. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: Prospective randomized study. Nephrol Dial Transplant. 2010; 25:2288–2296.
   PubMed Web of Science ®Google Scholar